PIRAMAL PHARMA
|
PIRAMAL PHARMA Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|
EQUITY AND LIABILITIES | |||
Share Capital | ₹1,193 Cr | ₹1,186 Cr | ₹995 Cr |
Equity - Authorised | ₹2,629 Cr | ₹1,500 Cr | ₹1,500 Cr |
Equity - Issued | ₹1,193 Cr | ₹1,186 Cr | ₹995 Cr |
Equity Paid Up | ₹1,193 Cr | ₹1,186 Cr | ₹995 Cr |
Equity Shares Forfeited | - | - | - |
Adjustments to Equity | - | - | - |
Preference Capital Paid Up | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | ₹0.10 Cr |
Total Reserves | ₹5,580 Cr | ₹5,511 Cr | ₹4,610 Cr |
Securities Premium | ₹3,819 Cr | ₹3,725 Cr | ₹3,249 Cr |
Capital Reserves | ₹407 Cr | ₹407 Cr | ₹407 Cr |
Profit & Loss Account Balance | ₹956 Cr | ₹1,159 Cr | ₹833 Cr |
General Reserves | - | - | - |
Other Reserves | ₹398 Cr | ₹220 Cr | ₹122 Cr |
Reserve excluding Revaluation Reserve | ₹5,580 Cr | ₹5,511 Cr | ₹4,610 Cr |
Revaluation reserve | - | - | - |
Shareholder's Funds | ₹6,774 Cr | ₹6,697 Cr | ₹5,605 Cr |
Minority Interest | - | - | - |
Long-Term Borrowings | - | - | - |
Secured Loans | ₹3,384 Cr | ₹2,622 Cr | ₹2,339 Cr |
Non Convertible Debentures | ₹399 Cr | ₹199 Cr | - |
Converible Debentures & Bonds | - | - | - |
Packing Credit - Bank | - | - | - |
Inter Corporate & Security Deposit | - | - | - |
Term Loans - Banks | ₹294 Cr | ₹278 Cr | ₹35 Cr |
Term Loans - Institutions | ₹2,691 Cr | ₹2,145 Cr | ₹2,304 Cr |
Other Secured | - | - | - |
Unsecured Loans | - | - | - |
Fixed Deposits - Public | - | - | - |
Loans and advances from subsidiaries | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - |
Foreign Currency Convertible Notes | - | - | - |
Long Term Loan in Foreign Currency | - | - | - |
Loans - Banks | - | - | - |
Loans - Govt. | - | - | - |
Loans - Others | - | - | - |
Other Unsecured Loan | - | - | - |
Deferred Tax Assets / Liabilities | ₹-130 Cr | ₹-105 Cr | ₹-22 Cr |
Deferred Tax Assets | ₹465 Cr | ₹406 Cr | ₹285 Cr |
Deferred Tax Liability | ₹335 Cr | ₹301 Cr | ₹263 Cr |
Other Long Term Liabilities | ₹282 Cr | ₹240 Cr | ₹236 Cr |
Long Term Trade Payables | - | - | - |
Long Term Provisions | ₹276 Cr | ₹145 Cr | ₹6.78 Cr |
Total Non-Current Liabilities | ₹3,812 Cr | ₹2,903 Cr | ₹2,560 Cr |
Current Liabilities | - | - | - |
Trade Payables | ₹1,193 Cr | ₹1,026 Cr | ₹918 Cr |
Sundry Creditors | ₹1,193 Cr | ₹1,026 Cr | ₹918 Cr |
Acceptances | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - |
Other Current Liabilities | ₹1,305 Cr | ₹1,243 Cr | ₹1,141 Cr |
Bank Overdraft / Short term credit | - | - | - |
Advances received from customers | ₹201 Cr | ₹185 Cr | ₹72 Cr |
Interest Accrued But Not Due | - | - | - |
Share Application Money | - | - | - |
Current maturity of Debentures & Bonds | - | - | - |
Current maturity - Others | - | - | - |
Other Liabilities | ₹1,104 Cr | ₹1,058 Cr | ₹1,069 Cr |
Short Term Borrowings | ₹1,302 Cr | ₹659 Cr | ₹361 Cr |
Secured ST Loans repayable on Demands | ₹1,295 Cr | ₹617 Cr | ₹259 Cr |
Working Capital Loans- Sec | ₹1,295 Cr | ₹617 Cr | ₹259 Cr |
Buyers Credits - Unsec | - | - | - |
Commercial Borrowings- Unsec | - | - | - |
Other Unsecured Loans | ₹-1,287 Cr | ₹-575 Cr | ₹-157 Cr |
Short Term Provisions | ₹51 Cr | ₹190 Cr | ₹172 Cr |
Proposed Equity Dividend | - | - | - |
Provision for Corporate Dividend Tax | - | - | - |
Provision for Tax | ₹12 Cr | ₹156 Cr | ₹140 Cr |
Provision for post retirement benefits | - | - | ₹32 Cr |
Preference Dividend | - | - | - |
Other Provisions | ₹39 Cr | ₹34 Cr | - |
Total Current Liabilities | ₹3,851 Cr | ₹3,118 Cr | ₹2,591 Cr |
Total Liabilities | ₹14,437 Cr | ₹12,717 Cr | ₹10,756 Cr |
ASSETS | |||
Gross Block | ₹10,878 Cr | ₹9,510 Cr | ₹8,173 Cr |
Less: Accumulated Depreciation | ₹3,409 Cr | ₹2,631 Cr | ₹2,068 Cr |
Less: Impairment of Assets | - | - | - |
Net Block | ₹7,469 Cr | ₹6,879 Cr | ₹6,105 Cr |
Lease Adjustment A/c | - | - | - |
Capital Work in Progress | ₹853 Cr | ₹673 Cr | ₹400 Cr |
Non Current Investments | ₹212 Cr | ₹217 Cr | ₹123 Cr |
Long Term Investment | ₹212 Cr | ₹217 Cr | ₹123 Cr |
Quoted | - | - | - |
Unquoted | ₹212 Cr | ₹217 Cr | ₹123 Cr |
Long Term Loans & Advances | ₹494 Cr | ₹297 Cr | ₹152 Cr |
Other Non Current Assets | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr |
Total Non-Current Assets | ₹9,593 Cr | ₹8,565 Cr | ₹7,007 Cr |
Current Assets Loans & Advances | - | - | - |
Currents Investments | ₹427 Cr | ₹50 Cr | - |
Quoted | ₹413 Cr | ₹37 Cr | - |
Unquoted | ₹14 Cr | ₹13 Cr | - |
Inventories | ₹1,681 Cr | ₹1,389 Cr | ₹1,232 Cr |
Raw Materials | ₹728 Cr | ₹599 Cr | ₹449 Cr |
Work-in Progress | ₹335 Cr | ₹322 Cr | ₹318 Cr |
Finished Goods | ₹247 Cr | ₹98 Cr | ₹133 Cr |
Packing Materials | - | - | - |
Stores Ā and Spare | ₹172 Cr | ₹123 Cr | ₹78 Cr |
Other Inventory | ₹199 Cr | ₹246 Cr | ₹254 Cr |
Sundry Debtors | ₹1,799 Cr | ₹1,785 Cr | ₹1,575 Cr |
Debtors more than Six months | ₹127 Cr | ₹86 Cr | - |
Debtors Others | ₹1,775 Cr | ₹1,754 Cr | ₹1,622 Cr |
Cash and Bank | ₹308 Cr | ₹329 Cr | ₹406 Cr |
Cash in hand | ₹2.21 Cr | ₹0.09 Cr | ₹0.13 Cr |
Balances at Bank | ₹305 Cr | ₹306 Cr | ₹405 Cr |
Other cash and bank balances | - | ₹22 Cr | - |
Other Current Assets | ₹140 Cr | ₹94 Cr | ₹141 Cr |
Interest accrued on Investments | - | - | ₹0.16 Cr |
Interest accrued on Debentures | - | - | - |
Deposits with Government | - | - | - |
Interest accrued and or due on loans | ₹2.20 Cr | ₹0.29 Cr | - |
Prepaid Expenses | ₹77 Cr | ₹70 Cr | ₹63 Cr |
Other current_assets | ₹61 Cr | ₹24 Cr | ₹78 Cr |
Short Term Loans and Advances | ₹488 Cr | ₹505 Cr | ₹396 Cr |
Advances recoverable in cash or in kind | ₹146 Cr | ₹156 Cr | ₹121 Cr |
Advance income tax and TDS | ₹7.99 Cr | ₹85 Cr | ₹100 Cr |
Amounts due from directors | - | - | - |
Due From Subsidiaries | - | - | - |
Inter corporate deposits | - | - | - |
Corporate Deposits | - | - | - |
Other Loans & Advances | ₹334 Cr | ₹264 Cr | ₹174 Cr |
Total Current Assets | ₹4,843 Cr | ₹4,152 Cr | ₹3,749 Cr |
Net Current Assets (Including Current Investments) | ₹992 Cr | ₹1,034 Cr | ₹1,158 Cr |
Miscellaneous Expenses not written off | - | - | - |
Total Assets | ₹14,437 Cr | ₹12,717 Cr | ₹10,756 Cr |
Contingent Liabilities | ₹57 Cr | ₹45 Cr | ₹30 Cr |
Total Debt | ₹5,505 Cr | ₹4,023 Cr | ₹2,910 Cr |
Book Value | 56.76 | 56.47 | 56.35 |
Adjusted Book Value | 56.76 | 56.47 | 56.35 |
Compare Balance Sheet of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹20,419.0 Cr | 2.9% | 9.1% | 105.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹366,103.0 Cr | 0.7% | -4.8% | 57.3% | Stock Analytics | |
CIPLA | ₹114,230.0 Cr | 1.9% | -2.4% | 42.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,916.0 Cr | 0.1% | 3% | 12.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,939.2 Cr | 1.3% | 0.5% | 87.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,732.2 Cr | -5.4% | -4.1% | 20% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 2.9% |
9.1% |
105.8% |
SENSEX | -1.5% |
-2.6% |
17.8% |
You may also like the below Video Courses